Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdissa Negassa

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Archives of Otolaryngology--Head & Neck Surgery|May 18, 2011
Radiofrequency ablation of advanced head and neck cancerRandall P Owen, Sajid A Khan, Abdissa Negassa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Head and Neck Pathology|December 20, 2012
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinomaYufeng Li, Shuting Bai, William Carroll, et al.
The American Journal of Surgical Pathology|April 24, 2010
Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinomaMargaret Brandwein-Gensler, Richard V Smith, Beverly Wang, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Archives of Otolaryngology--Head & Neck Surgery|May 18, 2011
Radiofrequency ablation of advanced head and neck cancerRandall P Owen, Sajid A Khan, Abdissa Negassa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Head and Neck Pathology|December 20, 2012
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinomaYufeng Li, Shuting Bai, William Carroll, et al.
The American Journal of Surgical Pathology|April 24, 2010
Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinomaMargaret Brandwein-Gensler, Richard V Smith, Beverly Wang, et al.
Pageof 7